tiprankstipranks
Advertisement
Advertisement

CTXR Stock Latest News

Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
Company AnnouncementsCitius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results
6d ago
8K
CTXR
Citius Oncology advances LYMPHIR launch and global expansion
PremiumCompany Announcements
Citius Oncology advances LYMPHIR launch and global expansion
11d ago
8K
CTXR
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
PremiumCompany Announcements
Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
1M ago
8K
CTXR
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
PremiumCompany Announcements
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
1M ago
8K
CTXR
Citius Pharmaceuticals receives $3.8M through NJEDA program
PremiumThe Fly
Citius Pharmaceuticals receives $3.8M through NJEDA program
2M ago
CTXR
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
PremiumCompany AnnouncementsCitius Pharmaceuticals Posts First Revenue Amid Listing Risk
2M ago
8K
CTXR
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
Premium
The Fly
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
2M ago
CTOR
CTXR
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
Premium
The Fly
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
2M ago
CTOR
CTXR
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
PremiumThe Fly
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
2M ago
CTOR
CTXR
Is CTXR a Buy, Before Earnings?
PremiumPre-Earnings
Is CTXR a Buy, Before Earnings?
2M ago
CTXR
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
PremiumThe Fly
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
4M ago
CTOR
CTXR
Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
PremiumCompany Announcements
Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
4M ago
8K
CTXR
Citius Oncology to advance launch of Lymphir with Verix AI integration
PremiumThe FlyCitius Oncology to advance launch of Lymphir with Verix AI integration
5M ago
CTOR
CTXR
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
Premium
Company Announcements
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
6M ago
8K
CTXR
Citius Pharmaceuticals Secures $6M in Stock Offering
Premium
Company Announcements
Citius Pharmaceuticals Secures $6M in Stock Offering
6M ago
8K
CTXR
Citius Pharmaceuticals announces $6M registered direct offering priced ATM
PremiumThe Fly
Citius Pharmaceuticals announces $6M registered direct offering priced ATM
6M ago
CTXR
Citius Oncology announces distribution agreement with McKesson
PremiumThe Fly
Citius Oncology announces distribution agreement with McKesson
6M ago
MCK
CTOR
Citius Oncology signs exclusive commercialization agreement with EVERSANA
PremiumThe Fly
Citius Oncology signs exclusive commercialization agreement with EVERSANA
6M ago
CTOR
CTXR
Citius Oncology announces pricing of $9M registered direct offering
PremiumThe Fly
Citius Oncology announces pricing of $9M registered direct offering
7M ago
CTOR
CTXR
Citius Pharma Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsCitius Pharma Reports Q2 2025 Financial Results
8M ago
CTXR
Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year
Premium
The Fly
Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year
8M ago
CTXR
Citius Oncology signs distribution agreement for Lymphir with Cencora
Premium
The Fly
Citius Oncology signs distribution agreement for Lymphir with Cencora
9M ago
CTOR
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >